# Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer

> **NCT05534646** · PHASE2 · RECRUITING · sponsor: **Edwin Posadas, MD** · enrollment: 100 (estimated)

## Conditions studied

- Castration-resistant Prostate Cancer

## Interventions

- **DRUG:** Apalutamide
- **DRUG:** Carotuximab

## Key facts

- **NCT ID:** NCT05534646
- **Lead sponsor:** Edwin Posadas, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-27
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05534646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05534646, "Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05534646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*